Biotech Analyst Schimmer holds a conference call with Chairman & CEO Velleca who will provide an overview of the evolving EGFR mutations (EGFRm) landscape on May 22 at 1 pm hosted by Cantor Fitzgerald. Webcast Link
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDTX:
- Black Diamond price target lowered to $11 from $12 at H.C. Wainwright
- Black Diamond Therapeutics reports Q1 EPS (35c), consensus (43c)
- Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
- Black Diamond Therapeutics announces changes to board of directors
- Black Diamond Therapeutics Revamps Board Leadership
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue